Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CERC-501 in smoking behavior
NCT02641028Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aticaprant in Tobacco Use Disorder (TUD), sponsored by Janssen Pharmaceutical. Started Dec 2015; status: completed.
02
Drugs
aticaprant
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02641028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02641028.